Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

Published:2015-10-06 Issue:1 Volume:16 Page:
ISSN:1471-2164
Container-title:BMC Genomics
language:en
Short-container-title:BMC Genomics

Author:

Aramburu Ander,Zudaire Isabel,Pajares María J.,Agorreta Jackeline,Orta Alberto,Lozano María D.,Gúrpide Alfonso,Gómez-Román Javier,Martinez-Climent Jose A.,Jassem Jacek,Skrzypski Marcin,Suraokar Milind,Behrens Carmen,Wistuba Ignacio I.,Pio Ruben,Rubio Angel,Montuenga Luis M.

Funder

European Union

Spanish Ministry of Economy and Innovation

Government of Navarra, Department of Health

AECC Scientific Foundation

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biotechnology

Link

http://link.springer.com/content/pdf/10.1186/s12864-015-1935-0.pdf

Reference50 articles.

1. Reck M, Heigener DF, Mok T, Soria J-C, Rabe KF. Management of non-small-cell lung cancer: recent developments. Lancet. 2013;382:709–19.

2. NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet. 2010;375:1267–77.

3. Pignon J-P, Tribodet H, Scagliotti GV, Douillard J-Y, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552–9.

4. Goldstraw P, Crowley J, Groome PA, Rusch V, Sobin L, Committee IS, et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. J Thorac Oncol. 2007;2:706–14.

5. Wistuba II, Behrens C, Lombardi F, Wagner S, Fujimoto J, Raso MG, et al. Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res. 2013;19:6261–71.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An enriched approach to combining high-dimensional genomic and low-dimensional phenotypic data;Journal of Biopharmaceutical Statistics;2024-04-05

2. A renaissance for YES in cancer;Oncogene;2023-10-17

3. Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer;JCO Clinical Cancer Informatics;2023-07

4. Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma;Genome Medicine;2022-11-21

5. YES1: A Novel Therapeutic Target and Biomarker in Cancer;Molecular Cancer Therapeutics;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3